Marina Biotech, Tekmira Pharmaceuticals Inc. deal

Marina Biotech granted Tekmira a non-exclusive, worldwide license to develop and commercialize RNAi therapeutics using Marina Biotech's Unlocked Nucleobase Analog (UNA) technology for undisclosed indi...